Development of a Putative Adverse Outcome Pathway (AOP) for the identification of substances with a potential link to Alzheimer's Disease (AD) / M. Midali, M.W. Wojewodzic, K. Audouze, E. Bernardini, T. Coustillet, X. Coumoul, C. Durand, A. Georgiou, A. Girardon, T. Hofer, K. Jagiello, B. Judzinska, A. Karakoltzidis, C. Ibanez, O. Laurent, C. Mandin, N. Papaioannou, F. Rampichini, E. Renieri, C. Samieri, D.A. Sarigiannis, M.M. Serafini, D. Schultz, M. Stepnik, S. Kumar, V. Kumar, A. Stratidakis, O. Myhre, B. Viviani. - In: TOXICOLOGY LETTERS. - ISSN 0378-4274. - 399:Supplement 2(2024), pp. P04-04.S129-P04-04.S129. ( 58. EUROTOX : Congress of the European Societies of Toxicology : September, 8 - 12 Copenhagen 2024) [10.1016/j.toxlet.2024.07.331].
Development of a Putative Adverse Outcome Pathway (AOP) for the identification of substances with a potential link to Alzheimer's Disease (AD)
M. MidaliPrimo
;M.M. Serafini;B. Viviani
2024
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0378427424014115-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Licenza:
Nessuna licenza
Dimensione
223.49 kB
Formato
Adobe PDF
|
223.49 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
